SA
IDXX icon

SpiderRock Advisors’s Idexx Laboratories IDXX Stock Holding History

SpiderRock Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.48M Sell
8,862
-821
-8% -$399K 0.07% 184
2024
Q2 		$4.72M Buy
9,683
+1,192
+14% +$598K 0.09% 158
2024
Q1 		$4.5M Buy
+8,491
New +$4.64M 0.11% 147
2017
Q3 		– Hold
0
– – – 48

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SpiderRock Advisors's IDXX Position: Q3 2024 in Review

SpiderRock Advisors reduced its Idexx Laboratories (IDXX) stake by 8.5% in Q3 2024, selling an estimated $399K and leaving 8,862 shares worth $4.48M. The position accounts for 0.07% of the portfolio, ranked #184.

SpiderRock Advisors first reported a position in IDXX in Q1 2024 and has held it in 3 quarters since. The position peaked at $4.72M in Q2 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • SpiderRock Advisors held 8,862 shares of Idexx Laboratories worth $4.48M as of Q3 2024.
  • SpiderRock Advisors sold 821 Idexx Laboratories shares in Q3 2024, an estimated $399K.
  • Idexx Laboratories made up 0.07% of SpiderRock Advisors's portfolio in Q3 2024, its #184 holding.
  • SpiderRock Advisors first reported a position in Idexx Laboratories in Q1 2024 and has held it in 3 quarters since.
  • SpiderRock Advisors's Idexx Laboratories position peaked at $4.72M in Q2 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.